Please login to the form below

Not currently logged in
Email:
Password:

Patient

This page shows the latest Patient news and features for those working in and with pharma, biotech and healthcare.

GSK preps filings for BCMA-targeting multiple myeloma drug

GSK preps filings for BCMA-targeting multiple myeloma drug

1 which revealed a 60% ORR with the drug in patients with BCMA-positive myeloma. ... was “excited about what this data could mean for patients with multiple myeloma who have exhausted other lines of treatment”.

Latest news

More from news
Approximately 206 fully matching, plus 6,092 partially matching documents found.

Latest Intelligence

  • AI is transforming pharma R&D – now it can transform pharma marketing AI is transforming pharma R&D – now it can transform pharma marketing

    Almost 50% of Babylon Health’s patients are aged 20 to 29, illustrating the demand for instant healthcare support from the young adult population. ... We felt a chatbot was the most effective way to provide 24/7 patient support.”.

  • The evolution of real-world studies The evolution of real-world studies

    We appreciate that our partnership with the FDA has allowed us to take a significant step forward in the use of real-world data to bring medicines to patients who are ... That is part of the appeal of RWE, as it may be more representative of how real

  • Why everyone in pharma is bending over backwards to be agile Why everyone in pharma is bending over backwards to be agile

    The paradigm shift from a controlling hierarchy to empowered teams allows organisations to focus on creating value for all stakeholders and partners, including patients, customers and healthcare providers, not just shareholder

  • The fight for affordable insulin The fight for affordable insulin

    The monthly wholesale price of Humulin, the most popular insulin in type 2 patients, rose to nearly $1, 100 between 2010 and 2015, up from $258 for the average patient. ... patients. In some ways it is a distraction from our advocacy and our push for

  • The Cystic Fibrosis Buyers’ Club The Cystic Fibrosis Buyers’ Club

    Gador has offered a year’s supply of Lucaftor for £23, 000 per patient, with additional discount to £18, 000 if the club can get 500 people involved. ... Gador. As of early July 2019, McDonald said: “Patients are liaising with their NHS teams and

More from intelligence
Approximately 90 fully matching, plus 753 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 454 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 231 fully matching, plus 980 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics